Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Indo Us Bio-Tech Ltd - 541304 - Revised-Financial Results For March, 31, 2022

 This is to inform that there was an inadvertent typo error in the submitted Standalone Financial Results dated 30.05.2022. Suo-motto we are submitting the Revised Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We hereby enclose the following documents again. 1. Revised Statement of Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2022. 2. Consolidated Audited Financial Results of the Company for quarter and year ended on 31st March, 2022. 3. Auditors'''' Report on Standalone and Consolidated Audited Financial Results. These Revised File is also being made available on the website of the Company at www.indousagriseeds.com. Please take the same on your records.
03-06-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Revised-Financial Results For March, 31, 2022

 This is to inform that there was an inadvertent typo error in the submitted Standalone Financial Results dated 30.05.2022. Suo-motto we are submitting the Revised Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We hereby enclose the following documents again. 1. Revised Statement of Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2022. 2. Consolidated Audited Financial Results of the Company for quarter and year ended on 31st March, 2022. 3. Auditors'' Report on Standalone and Consolidated Audited Financial Results. These Revised File is also being made available on the website of the Company at www.indousagriseeds.com. Please take the same on your records.
03-06-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Results- Financial Results For March, 31 2022

 With reference to above, we hereby inform that meeting of Board of Directors of the Company was held today (i.e., 30/05/2022), in which Board has approved and adopted the standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March, 2022. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following: 1. Standalone and Consolidated Audited Financial Results of the Company for quarter and year ended on 31st March, 2022. 2. Auditors'' Report on Standalone and Consolidated Audited Financial Results. These are also being made available on the website of the Company at www.indousagriseeds.com. Please take the same on your records. Thanking you,
30-05-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On 30Th May, 2022 And Submission Of Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2022.

 With reference to above, we hereby inform that meeting of Board of Directors of the Company was held today (i.e., 30/05/2022), in which Board has approved and adopted the standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March, 2022. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following: 1. Standalone and Consolidated Audited Financial Results of the Company for quarter and year ended on 31st March, 2022. 2. Auditors'' Report on Standalone and Consolidated Audited Financial Results. These are also being made available on the website of the Company at www.indousagriseeds.com. The meeting of Board of Directors commenced at 04.30 p.m and concluded at 06.30 p.m. Please take the same on your records. Thanking you,
30-05-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Indo Us Bio-Tech Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
27-05-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Details Of Voting Results With Respect To The Extra Ordinary General Meeting And Scrutinizer''s Consolidated Report

 Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed the details of voting results with respect to Extra Ordinary General Meeting of the Company held on Wednesday, 25th Day of May, 2022 at 11:02 a.m. at through electronic mode (video conference or other audio-visual means) as per the format prescribed. Further, the results are also being uploaded on website of the Company at https://www.indousagriseeds.com/ Also, please find enclosed, for your records the report issued by the Scrutinizer i.e., Mr. Ajit Santoki, FCS Proprietor of M/s. A. Santoki & Associates, Company Secretaries We request you to take the aforesaid on records. Thanking you,
26-05-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Outcome Of Extra Ordinary General Meeting (EGM)

 With reference to above captioned manner and in compliance with the regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''''''''The Listing Regulations''''''''), we are enclosing herewith the proceedings of Extra Ordinary General Meeting of the Members held on today i.e. Wednesday, 25th Day of May, 2022 at 11.02 a.m. through video conferencing and other audio-visual means. Please take the same on your record.
25-05-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2022. Further please be informed that, pursuant to "Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons" of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and as per our earlier submission vide letter dated March 31, 2022, the trading window of the Company has been closed for all Designated Persons and their immediate relatives with effect from April 01, 2022 and would remain closed until 48 hours after the announcement of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2022 to the Stock Exchange. Kindly take the same on your record.
24-05-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Submission Of Second Addendum To The Notice Dated May 3, 2022 Convening EGM.

 In reference to the captioned subject, the Management hereby has resolved and approved to make changes to few typographical errors in Addendum and to Notice of EGM. Thus, the management of the Company have concluded to issue second addendum to the erstwhile notice and first addendum for information and perusal by the members. The said addendum is being sent to the members via e-mail. A copy of said addendum is enclosed herewith for your records and information please. Request you to kindly disseminate the same on website of Exchange for prompt information of our stakeholders. Thanking You,
11-05-2022
Bigul

Indo Us Bio-Tech Ltd - 541304 - Submission Of Addendum To The Notice Dated May 3, 2022 Convening EGM

 In reference to the captioned subject, it had come to knowledge of Management, post sending the notice, that addition / alteration of certain details and information in the original Notice would make it more convenient for stakeholders and members to take an informed decision and to apprise the facts and nitty gritty of the agenda proposed in the ensuing meeting. Thus, the management of the Company have concluded to issue an addendum to the erstwhile notice for information and perusal by the members. The said addendum is being sent to the members via e-mail. A copy of said addendum is enclosed herewith for your records and information please. Request you to kindly disseminate the same on website of Exchange for prompt information of our stakeholders. Thanking You,
10-05-2022
Next Page
Close

Let's Open Free Demat Account